Nicolaas I. Bohnen

14.8k total citations · 2 hit papers
189 papers, 10.4k citations indexed

About

Nicolaas I. Bohnen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Nicolaas I. Bohnen has authored 189 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Neurology, 41 papers in Cellular and Molecular Neuroscience and 38 papers in Psychiatry and Mental health. Recurrent topics in Nicolaas I. Bohnen's work include Parkinson's Disease Mechanisms and Treatments (96 papers), Neurological disorders and treatments (63 papers) and Dementia and Cognitive Impairment Research (22 papers). Nicolaas I. Bohnen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (96 papers), Neurological disorders and treatments (63 papers) and Dementia and Cognitive Impairment Research (22 papers). Nicolaas I. Bohnen collaborates with scholars based in United States, Netherlands and Italy. Nicolaas I. Bohnen's co-authors include Martijn L.T.M. Müller, Roger L. Albin, Kirk A. Frey, Robert A. Koeppe, Vikas Kotagal, Satoshi Minoshima, J. Jolles, A. Twijnstra, Stephanie A. Studenski and Peter J. H. Scott and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Nicolaas I. Bohnen

180 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

2013 402 citations Satoshi Minoshima, Nicolaas I. Bohnen et al. profile →
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches

2022 145 citations Nicolaas I. Bohnen, Per Borghammer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicolaas I. Bohnen United States	57	5.3k	2.3k	2.3k	2.2k	1.7k	189	10.4k
Jan Booij Netherlands	62	5.9k 1.1×	2.0k 0.9×	4.4k 1.9×	2.0k 0.9×	1.5k 0.9×	349	13.6k
Ubaldo Bonuccelli Italy	56	6.6k 1.3×	2.1k 0.9×	2.5k 1.1×	1.7k 0.8×	1.5k 0.9×	365	11.1k
Erik Ch. Wolters Netherlands	44	4.6k 0.9×	2.1k 0.9×	1.9k 0.8×	1.5k 0.7×	1.7k 1.0×	132	9.0k
Jaime Kulisevsky Spain	55	9.4k 1.8×	3.3k 1.4×	2.8k 1.2×	3.9k 1.8×	1.5k 0.9×	321	13.8k
Murat Emre Türkiye	47	7.1k 1.4×	3.2k 1.4×	1.9k 0.8×	2.4k 1.1×	2.2k 1.3×	164	11.9k
Marco Onofrj Italy	51	4.1k 0.8×	1.7k 0.7×	1.7k 0.7×	2.8k 1.3×	1.2k 0.7×	317	9.1k
Joel S. Perlmutter United States	65	8.1k 1.5×	1.4k 0.6×	4.4k 1.9×	2.7k 1.2×	1.7k 1.0×	385	14.3k
Kenneth Marek United States	52	9.9k 1.9×	1.2k 0.5×	3.5k 1.5×	1.8k 0.8×	2.0k 1.2×	189	13.5k
Jody Corey‐Bloom United States	52	2.0k 0.4×	3.4k 1.5×	1.3k 0.6×	2.5k 1.2×	3.2k 1.8×	160	9.3k
Piu Chan China	51	7.6k 1.4×	1.1k 0.5×	2.7k 1.2×	2.2k 1.0×	2.5k 1.4×	189	13.5k

Countries citing papers authored by Nicolaas I. Bohnen

Since Specialization

Citations

This map shows the geographic impact of Nicolaas I. Bohnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolaas I. Bohnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolaas I. Bohnen more than expected).

Fields of papers citing papers by Nicolaas I. Bohnen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolaas I. Bohnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolaas I. Bohnen. The network helps show where Nicolaas I. Bohnen may publish in the future.

Co-authorship network of co-authors of Nicolaas I. Bohnen

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolaas I. Bohnen. A scholar is included among the top collaborators of Nicolaas I. Bohnen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolaas I. Bohnen. Nicolaas I. Bohnen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bohnen, Nicolaas I., Sygrid van der Zee, Kirk A. Frey, et al.. (2025). A multicenter longitudinal study of cholinergic subgroups in Parkinson disease. Nature Communications. 16(1). 5655–5655. 1 indexed citations

Chou, Kelvin L., et al.. (2025). Cholinergic System Changes in Dopa‐Unresponsive Freezing of Gait in Parkinson's Disease. Movement Disorders. 40(8). 1584–1594.

Kanel, Prabesh, et al.. (2024). Regional cerebral cholinergic vesicular transporter correlates of visual contrast sensitivity in Parkinson's disease: Implications for visual and cognitive function. Parkinsonism & Related Disorders. 131. 107229–107229. 2 indexed citations

Okkels, Niels, Michel J. Grothe, John‐Paul Taylor, et al.. (2024). Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes. Brain. 147(7). 2308–2324. 21 indexed citations

Marras, Connie, Seyed‐Mohammad Fereshtehnejad, Daniela Berg, et al.. (2024). Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach. Movement Disorders. 39(3). 462–471. 21 indexed citations

Bohnen, Nicolaas I., Uroš Marušič, Peter J. H. Scott, et al.. (2024). Dynamic balance and gait impairments in Parkinson’s disease: novel cholinergic patterns. Brain Communications. 6(5). fcae286–fcae286. 1 indexed citations

Postuma, Ronald B., Tanya Simuni, Mayela Rodríguez‐Violante, et al.. (2024). Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome. Movement Disorders Clinical Practice. 11(8). 983–991. 3 indexed citations

Bohnen, Nicolaas I., et al.. (2023). GABAA Receptor Benzodiazepine Binding Sites and Motor Impairments in Parkinson’s Disease. Brain Sciences. 13(12). 1711–1711. 4 indexed citations

Bohnen, Nicolaas I., et al.. (2023). Ketogenic-Mimicking Diet as a Therapeutic Modality for Bipolar Disorder: Biomechanistic Rationale and Protocol for a Pilot Clinical Trial. Nutrients. 15(13). 3068–3068. 6 indexed citations

10.

Koeppe, Robert A., et al.. (2023). Cholinergic system correlates of postural control changes in Parkinson’s disease freezers. Brain. 146(8). 3243–3257. 18 indexed citations

11.

Kanel, Prabesh, Robert A. Koeppe, Vikas Kotagal, et al.. (2023). Regional serotonin terminal density in aging human brain: A [11C]DASB PET study. SHILAP Revista de lepidopterología. 3. 100071–100071. 1 indexed citations

12.

Zee, Sygrid van der, Prabesh Kanel, Marleen J. J. Gerritsen, et al.. (2022). Altered Cholinergic Innervation in De Novo Parkinson's Disease with and Without Cognitive Impairment. Movement Disorders. 37(4). 713–723. 50 indexed citations

13.

Albin, Roger L., Prabesh Kanel, Teus van Laar, et al.. (2022). No Dopamine Agonist Modulation of Brain [¹⁸F]FEOBV Binding in Parkinson’s Disease. Molecular Pharmaceutics. 19(4). 1176–1182. 5 indexed citations

14.

Sánchez-Catasús, Carlos A., Nicolaas I. Bohnen, Nicholas D’Cruz, & Martijn L.T.M. Müller. (2021). Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational Tractography. Journal of Nuclear Medicine. 63(3). 438–445. 35 indexed citations

15.

Albin, Roger L., Martijn L.T.M. Müller, Nicolaas I. Bohnen, et al.. (2021). α4β2 ^* Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders. Annals of Neurology. 90(1). 130–142. 15 indexed citations

16.

Bohnen, Nicolaas I., Prabesh Kanel, & Martijn L.T.M. Müller. (2018). Molecular Imaging of the Cholinergic System in Parkinson's Disease. International review of neurobiology. 141. 211–250. 50 indexed citations

17.

Kwak, Youngbin, Martijn L.T.M. Müller, Nicolaas I. Bohnen, Praveen Dayalu, & Rachael D. Seidler. (2012). l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease. Behavioural Brain Research. 230(1). 116–124. 37 indexed citations

18.

Bohnen, Nicolaas I., Roger L. Albin, Martijn L.T.M. Müller, & Kelvin L. Chou. (2012). Advances in Therapeutic Options for Gait and Balance in Parkinson’s Disease. European Neurological Review. 7(3). 160–160. 3 indexed citations

19.

Bohnen, Nicolaas I., Robert A. Koeppe, Satoshi Minoshima, et al.. (2011). Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study. Journal of Nuclear Medicine. 52(6). 848–855. 172 indexed citations

20.

Bohnen, Nicolaas I., et al.. (1992). Lower blood levels of vitamin B12 are related to decreased performance of healthy subjects in the Stroop Color-Word Test. Neuroscience Research Communications. 11(1). 53–56. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact